Company: STAA
Filing Date: 2025-10-02
Form Type: DFAN14A
Source: 0001213900-25-095514
Chunk: 7

Company: STAAR SURGICAL CO
Filing Date: 2025-10-02
Form: DFAN14A
Chunk 7
---
+ lens will serve as a catalyst for growth ▪ Outside of China, STAAR continues to perform well and has been delivering solid growth as ICL sales have outpaced the broader market ▪ ICLs enjoy many advantages over other refractive procedures and are expected to continue to take market share from other procedures; the advantages of ICLs over LASIK have become even more apparent following the publication of recent data, which we expect to drive further adoption ▪ In all events, in the long - term, STAAR is supported by favorable tailwinds, as myopia is expected to continue to proliferate over the coming years and decades ▪ STAAR’s management itself expects the Company to grow quickly and become more profitable than ever within the next 18 months ▪ Over the last year, STAAR has been navigating temporary macroeconomic headwinds and tactical challenges that have weighed on the Company’s financial results, stock price and valuation ▪ The refractive surgery market, especially in China, STAAR’s largest market, has been experiencing a period of softer demand due to diminished consumer confidence and spending ▪ Compounding these near - term macroeconomic headwinds has been the fact that STAAR’s previous management team delivered excess inventory to the Company’s Chinese distributors — STAAR’s sales in China temporarily dropped to nearly zero as the Company’s distributors worked through the excess inventory ▪ After the Company’s inventory issues and reduced revenue outlook were disclosed in February 2025, STAAR’s stock price declined by approximately 25%, and sell - side analysts slashed their price targets A B 1. Source: STAAR Quarterly Report on Form 10 - Q for the period ended June 27, 2025 at 23. STAAR has a bright future as a standalone company

Broadwood Partners, L.P. STAAR Has Been Facing Temporary Tactical Challenges… 11 Alcon is taking advantage of what has been a turbulent period for STAAR and a temporary dislocation in its stock price 1. Source: FactSet. Data from January 1, 2024 to September 23, 2025. Apr 19, 2024 Alcon’s CEO sends STAAR’s then - CEO a non - binding offer letter proposing that Alcon acquire STAAR for $58 per share in cash Oct 29, 2024 Alcon’s CEO sends STAAR’s then - CEO a non - binding offer letter proposing that Alcon acquire STAAR for $55 per share in cash, plus one contingent value right valued at